Wytske M. van Weerden

Erasmus University Medical Center

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (20)

Collaborators (15)

Elena Martens-Uzunova

Erasmus University Rotterdam

Stefan Buck

Jack A. Schalken

Shuiying Hu

Ohio State University

UNITED STATES

Guido Jenster

Professor Experimental Urological Oncology

Simone Dalm

Assistant Professor, PI

Pim French

Dik C. van Gent

Erasmus University Rotterdam

W. Nathaniel Brennen

Associate Professor

Johns Hopkins University School of Medicine

UNITED STATES

Renea Taylor

MONASH UNIVERSITY

Martin van Royen

Assistant Professor

Natalie Lister

MONASH UNIVERSITY

Hub Zwart

Full professor and Dean

Erasmus University Rotterdam

Harmen van de Werken

Assistant Professor Computational Biology & Bioinformatics at the Department of Immunology

Jan Bouchal

Palacký University, Olomouc

CZECH REPUBLIC

Wytske M. van Weerden

Research Interests

Explore related searches

Contact this professor

Articles (20)

Reticuloendothelial system blockade does not enhance siRNA-LNP circulation or tumor accumulation in mice

Darolutamide does not interfere with OATP‐mediated uptake of docetaxel

Defining the challenges and opportunities for using patient‐derived models in prostate cancer research

Pre-existing cell subpopulations in primary prostate cancer tumors display surface fingerprints of docetaxel-resistant cells

Capivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer

Darolutamide added to docetaxel augments antitumor effect in models of prostate cancer through cell cycle arrest at the G1-S transition

Prostate cancer androgen biosynthesis relies solely on CYP17A1 downstream metabolites

The future of patient-derived xenografts in prostate cancer research

Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids

Androgen receptor mutations modulate activation by 11-oxygenated androgens and glucocorticoids

Awe and anxiety for cancer cells: connecting scientists and patients in a holistic approach of metastasis research

GRPR versus PSMA

Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling

Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment

Abiraterone switches castration‐resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling

Radiolabeled Bombesin Analogs

Modeling Prostate Cancer Treatment Responses in the Organoid Era: 3D Environment Impacts Drug Testing

Patient-Derived Xenograft Models in Cancer Research

The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel‐resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe

NanoBiT System and Hydrofurimazine for Optimized Detection of Viral Infection in Mice—A Novel in Vivo Imaging Platform

Collaborators (15)

Elena Martens-Uzunova

Stefan Buck

Jack A. Schalken

Shuiying Hu

Guido Jenster

Simone Dalm

Pim French

Dik C. van Gent

W. Nathaniel Brennen

Renea Taylor

Martin van Royen

Natalie Lister

Hub Zwart

Harmen van de Werken

Jan Bouchal

How do I reach out?

Meet Kite AI